Source comparison
Ipamorelin Side Effects: Clinical Comparison
Water retention (hands, feet, face) 15–25% 24–48 hours post-injection 4–6 hours per episode; resolves after 2 weeks GH-induced sodium reabsorption in renal distal tubules Normal response; self-limiting; reduce sodium intake Injection site reactions (redness, t
This comparison does not assign a generated winner or score.
- Water retention (hands, feet, face)
- 15–25%
- 24–48 hours post-injection
- 4–6 hours per episode; resolves after 2 weeks
- GH-induced sodium reabsorption in renal distal tubules
- Normal response; self-limiting; reduce sodium intake
- Injection site reactions (redness, tenderness)
- 10–15%
- Immediate to 2 hours
- 12–24 hours
- Benzyl alcohol irritation or improper injection technique
- Technique error; rotate sites; consider sterile saline
- Transient flushing or warmth
- 8–12%
- 15–30 minutes post-injection
- 20–40 minutes
- Lipolysis-induced free fatty acid release and oxidation
- Positive pharmacological sign; no intervention needed
- Mild frontal or temporal headaches
- 5–8%
- Within 6 hours of first dose
- 30–90 minutes per episode
- Possible cerebral vasodilation via nitric oxide modulation
- Dose-dependent; resolves within 72 hours; OTC analgesics effective
- Transient hyperglycemia (fasting glucose +10–15 mg/dL)
- 3–5%
- 1–2 hours post-injection
- 2–4 hours
- GH-stimulated hepatic glucose output
- Monitor in diabetic subjects; no intervention in healthy subjects
- Cortisol suppression (chronic use >12 weeks)
- Rare (<2%)
- After 8–12 weeks of daily use
- Variable; requires dose cessation
- Disruption of HPA axis feedback via sustained GH elevation
- Warrants protocol review; cycle peptides or reduce frequency